The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Lilly
Assessment of ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients (pts) with advanced HER2-negative gastric or gastroesophageal junction cancers: The ARMANI phase III trial.
 
Federica Morano
No Relationships to Disclose
 
Monica Niger
No Relationships to Disclose
 
Salvatore Corallo
No Relationships to Disclose
 
Sara Lonardi
Consulting or Advisory Role - Amgen; Lilly; Merck Serono
Speakers' Bureau - Bristol-Myers Squibb; Lilly; Merck Serono; Roche; Servier
Research Funding - Amgen; Merck Serono
 
Stefano Tamberi
No Relationships to Disclose
 
Samantha Di Donato
No Relationships to Disclose
 
Elisa Giommoni
Honoraria - Baxter; Lilly
Consulting or Advisory Role - Baxter; Lilly
 
Francesco Giuliani
No Relationships to Disclose
 
Giovanni Luca Frassineti
No Relationships to Disclose
 
Gianluca Tomasello
No Relationships to Disclose
 
Ferdinando De Vita
No Relationships to Disclose
 
Giovanni Gerardo Cardellino
No Relationships to Disclose
 
Graziella Pinotti
No Relationships to Disclose
 
Maria Pia Brizzi
No Relationships to Disclose
 
Lorenza Rimassa
Honoraria - Abbvie; AstraZeneca; Gilead Sciences; Roche
Consulting or Advisory Role - Amgen; ArQule; Baxter; Bayer; Celgene; Eisai; Exelixis; Incyte; Ipsen; Italfarmaco; Lilly; Sanofi; Sirtex Medical
Travel, Accommodations, Expenses - ArQule; Ipsen
 
Mario Scartozzi
No Relationships to Disclose
 
Rossana Berardi
No Relationships to Disclose
 
Filippo G. De Braud
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Daiichi Sankyo; Dompè; Ignyta; Incyte; Novartis; Octimet; Pfizer; Pierre Fabre; Roche; SERVIER
Speakers' Bureau - Bristol-Myers Squibb; Menarini; MSD; Novartis; Pfizer; Roche
Research Funding - Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Ignyta (Inst); Lilly (Inst); MedImmune (Inst); Merck Serono (Inst); MSD (Inst); Nektar (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Roche
 
Filippo Pietrantonio
Honoraria - Amgen; Bayer; Lilly; Merck Serono; Roche; Sanofi; SERVIER
Consulting or Advisory Role - Amgen; Bayer; Lilly; Merck Serono; Roche; Sanofi; SERVIER
 
Maria Di Bartolomeo
Consulting or Advisory Role - Lilly; SERVIER
Travel, Accommodations, Expenses - Roche; SERVIER